Advances in Cancer Immunotherapy™: A Focus on Gynecologic Cancers

When:  Nov 16, 2023 from 09:00 to 13:00 (ET)
This program will be hosted virtually.


Stephanie Gaillard, MD, PhD - Johns Hopkins Medicine
Kayla Garzio, PharmD, BCPS, BCOP - The Johns Hopkins Hospital
Melissa A. Geller, MD, MS, FACOG - University of Minnesota

Program Purpose

Specifically designed by the Society for Immunotherapy of Cancer (SITC) for practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading authorities in tumor immunology and cancer immunotherapy, at the conclusion of this activity, participants of this should be able to:

  • Identify the cancer immunotherapy approaches in use for the treatment of gynecologic cancers.
  • Summarize recent updates in cancer immunotherapy for gynecologic cancers including emerging toxicities and management.
  • Implement cancer immunotherapy for gynecologic cancer into clinical practice appropriately.
Attendees will also have an opportunity for connecting with experts in the immunotherapy field at the virtual event, through four quarterly webinars, and indefinitely through a dedicated online community forum. These connections will serve as ongoing resources while clinical oncologists and other healthcare providers incorporate immunotherapy into practice.

For more information on the program, click below.

View the SITC Meeting Code of Conduct.